The Facts About Lyme Disease

Introduction

Lyme disease has emerged as a significant global health concern, with its prevalence and impact increasingly recognized worldwide. It is estimated that approximately 14% of the world's population has been diagnosed with this tick-borne illness. In certain regions of Europe, the occurrence is even higher, affecting up to 20% of the population, while in North America, around 9% have been diagnosed. This widespread distribution underscores that Lyme disease is not confined to specific areas but represents a substantial global health challenge. The varying rates across continents and regions could be attributed to a multitude of factors, including differences in the populations of ticks that carry the disease, diverse environmental conditions that favor tick survival, and variations in diagnostic practices and reporting standards.

Within the United States, the impact of Lyme disease is also considerable. Recent estimates suggest that approximately 476,000 individuals may be diagnosed and treated for the condition each year. This figure is notably higher than the number of cases officially reported, indicating a potential underestimation of the true burden of the disease and highlighting challenges in accurate diagnosis and surveillance. Notably, reported cases in the US experienced a significant surge in 2022, reaching 62,551, which represents a 68.5% increase compared to the average reported during the period of 2017 to 2019. This increase can be partly attributed to changes in the reporting requirements for Lyme disease cases, which likely led to a more comprehensive capture of diagnoses. Beyond the health implications, Lyme disease also carries a substantial economic burden. It is estimated that the cost associated with diagnosed Lyme disease in the US could be nearly $1 billion annually. This significant financial impact underscores the need for effective prevention strategies, accurate diagnostic tools, and optimal treatment protocols to mitigate both the personal and societal costs of this illness. The considerable difference between reported and estimated cases within the US strongly suggests that the actual impact of Lyme disease is likely underestimated. This underestimation could have far-reaching consequences, potentially affecting the allocation of public health resources and the prioritization of research funding for this growing infectious disease. The global prevalence data, when considered alongside the trends observed in the US, points towards a widespread dissemination of Lyme disease across the planet. This extensive reach, coupled with the complexities surrounding its diagnosis and treatment, emphasizes the necessity of a coordinated global effort in research, surveillance, and public health education to effectively address this pervasive health issue.

What is Lyme Disease? Unraveling the Cause and Transmission

Lyme disease is an infectious illness caused by bacteria belonging to the Borrelia genus. In the United States, the primary culprit is the spirochete bacterium Borrelia burgdorferi, with Borrelia mayonii being a less common cause. These bacteria are transmitted to humans through the bite of infected ticks, primarily black-legged ticks of the Ixodes genus in the US. Understanding the role of these ticks in the transmission process is crucial for effective prevention. Black-legged ticks have a two-year life cycle, progressing through larval, nymphal, and adult stages. During each stage, the tick requires a blood meal to survive and molt. It is during these blood meals that the tick can acquire the Borrelia bacteria, typically by feeding on infected animals, particularly small mammals such as the white-footed mouse. Once infected, the tick can then transmit the bacteria to its next host, which may include humans.

It is important to note that the primary tick vectors can vary geographically. In the Western United States, the Western black-legged tick (Ixodes pacificus) is the main carrier, and the grey squirrel serves as a significant host for this tick species. This regional difference highlights that the ecological dynamics of Lyme disease transmission can differ based on location, influencing the specific prevention measures that may be most effective. Furthermore, in Europe and Asia, Lyme disease can be caused by other species of Borrelia, such as Borrelia afzelii and Borrelia garinii. This global diversity in the causative agents and their vectors underscores the worldwide distribution of Lyme disease and the need for region-specific understanding and management strategies. The intricate relationship between the tick's life cycle and its dependence on host animals like the white-footed mouse establishes a clear ecological link to the prevalence of Lyme disease. Consequently, factors that influence these host populations, such as alterations in climate patterns and changes in land use, can indirectly impact the risk of human infection. For instance, shifts in the population density or geographical distribution of white-footed mice can affect the number of infected ticks present in a given area. Understanding these complex ecological interactions is therefore essential for predicting and potentially mitigating the risk of Lyme disease transmission. The observation that different Borrelia species exhibit an affinity for specific tissues within the human body, such as B. burgdorferi tending to affect joints, B. garinii showing a predilection for nervous system tissue, and B. afzelii having an affinity for the skin, might explain some of the variability in the symptoms of Lyme disease reported in different parts of the world. This suggests that the clinical presentation of the illness may not be uniform globally and could depend on the particular strain of Borrelia involved, potentially adding to the complexity of diagnosis and treatment strategies in various geographical regions.

Navigating the Stages of Lyme Disease: Recognizing the Progression

Lyme disease can progress through three distinct stages if left untreated, each characterized by a different set of symptoms. Recognizing these stages is crucial for timely diagnosis and intervention.

• Early Localized Lyme Disease: This initial stage typically occurs within 1 to 28 days following the bite of an infected tick.
  • A hallmark of this stage is the Erythema Migrans (EM) rash, often described as a "bull's-eye" rash due to its appearance with a central red spot surrounded by a clear ring and an outer red ring. However, it's important to note that this classic presentation is not always present, and the rash can vary in appearance, size, and shape. It is estimated that the characteristic EM rash is seen in approximately 70% of patients with early Lyme disease.
    • Less than one-third of individuals with Lyme disease recall being bitten by a tick, and even fewer, less than one-third, exhibit the telltale bullseye rash, indicating that relying solely on a history of a tick bite or the presence of this specific rash can be misleading for diagnosis.
  • Alongside the rash, other flu-like symptoms may be present during this stage, including:
    • Fever and chills.
    • Fatigue and a general feeling of being unwell.
    • Headache.
    • Muscle aches (myalgia).
    • Neck stiffness.
    • Visual problems such as eye redness and tearing.
• Early Disseminated Lyme Disease: This stage develops weeks to months after the initial infection if it remains untreated. It signifies that the Borrelia bacteria have begun to spread throughout the body.
  • One indicator of this stage can be the appearance of multiple EM rashes at different locations on the body, indicating a wider dissemination of the infection.
  • Neurological manifestations may also occur, including:
    • Facial nerve (cranial nerve VII) palsy, which results in weakness or drooping on one side of the face.
    • Lymphocytic meningitis, an inflammation of the membranes surrounding the brain and spinal cord.
    • Radiculopathy, which involves pain, numbness, or weakness radiating along a nerve pathway.
  • Cardiac involvement is also possible, with manifestations such as:
    • Lyme carditis, an inflammation of the heart tissue that can sometimes lead to heart block, disrupting the normal electrical activity of the heart.
• Late Disseminated Lyme Disease: This stage can develop months to years after the initial infection if it is not adequately treated. It is characterized by the potential for long-term complications.
  • A common manifestation of late-stage Lyme disease is arthritis, particularly affecting large joints such as the knees. This can present as significant pain, swelling, and stiffness in the affected joints.
  • Neurological issues can also persist or develop in this stage, including:
    • Encephalopathy, which can involve cognitive impairment, such as difficulties with memory and concentration.
    • Peripheral neuropathy, which involves damage to the peripheral nerves, leading to symptoms like pain, numbness, or weakness in the extremities.

The progression through these three stages highlights the systemic nature of Lyme disease and its potential to affect various organ systems throughout the body. The fact that initial symptoms can be variable and that some individuals may experience asymptomatic infection in the early stages (estimated to be between 1.6% and 7%) can lead to delays in both diagnosis and the initiation of appropriate treatment. Such delays can subsequently increase the risk of developing more severe complications in the later stages of the disease. The overlap in symptoms between Lyme disease and other medical conditions further complicates the diagnostic process. Many of the early symptoms, such as fever, fatigue, and headache, are non-specific and can be indicative of common viral infections. This underscores the critical importance of a thorough clinical evaluation by healthcare professionals, who need to consider Lyme disease in the differential diagnosis, especially for individuals residing in or having traveled to areas where Lyme disease is endemic or for those with a known history of potential tick exposure.

Table 1: Stages of Lyme Disease and Their Common Symptoms

Symptoms and Complications: Identifying the Warning Signs

Recognizing the various symptoms and potential complications of Lyme disease is essential for prompt diagnosis and management. The illness can manifest with a range of signs, varying in severity and affecting different parts of the body.

• Common Symptoms:
  • Erythema Migrans (EM) rash : This is often the first and most recognizable sign of Lyme disease.
    • It is classically described as a "bull's-eye" rash, but it can also appear as a solid red patch, an oval shape, or in other forms.
    • The rash may or may not be accompanied by itching or burning and can sometimes be asymptomatic.
    • It typically begins at the site of the tick bite and expands over several days, potentially reaching a diameter of 12 inches or more.
    • In some cases, multiple EM lesions can appear on different parts of the body.
  • Flu-like symptoms : These are common, particularly in the early stages of the infection.
    • Fever and chills.
    • Fatigue and a general feeling of being unwell (malaise).
    • Headache.
    • Muscle and joint aches (myalgia and arthralgia).
    • Swollen lymph nodes (lymphadenopathy).
• Severe Complications: If Lyme disease is left untreated, more severe complications can arise, affecting various organ systems.
  • Neurological involvement : The bacteria can spread to the nervous system, leading to conditions such as:
    • Lyme meningitis: Characterized by severe headache, stiff neck, and increased sensitivity to light (photophobia).
    • Facial palsy (Bell's palsy): A temporary weakness or paralysis of the muscles on one side of the face.
    • Radiculopathy: Involving shooting pains, numbness, or weakness in the arms or legs due to nerve root irritation.
    • Cognitive impairment: Including difficulties with memory, concentration, and other cognitive functions.
  • Cardiac issues (Lyme carditis) : The heart can also be affected, leading to:
    • Irregular heartbeat (arrhythmia): An abnormal rhythm of the heart, which can sometimes be serious.
    • Dizziness or fainting (syncope).
    • Shortness of breath (dyspnea).
    • Chest pain (angina).
  • Lyme arthritis : This typically affects the large joints, especially the knees, causing:
    • Severe joint pain and swelling.
    • If left untreated, Lyme arthritis can become chronic and lead to long-term joint damage.

The wide range of potential symptoms associated with Lyme disease, spanning from mild, flu-like manifestations to severe complications affecting the nervous system, heart, and joints, significantly contributes to the challenges in diagnosing this condition. The fact that many of the early symptoms are non-specific and can mimic other common illnesses, particularly in the initial stages, often leads to delays in obtaining an accurate diagnosis and receiving timely treatment. This diagnostic complexity underscores the importance for healthcare providers to maintain a high level of suspicion for Lyme disease, especially when patients present with a combination of suggestive symptoms and have a history of potential exposure to ticks, either through residence in or travel to endemic areas. Recognizing the potential for severe complications highlights the critical need for early diagnosis and prompt treatment of Lyme disease. When diagnosed and treated in its early stages, Lyme disease is typically responsive to antibiotic therapy, which can significantly reduce the risk of developing these more serious and potentially long-lasting health issues affecting the nervous system, the heart, and the joints. Therefore, increased awareness of the early signs and symptoms, coupled with timely medical intervention, plays a pivotal role in preventing the progression of Lyme disease to its more severe and debilitating forms.

Diagnosis: Challenges and Methods in Detection

Diagnosing Lyme disease can be complex, and it primarily relies on a combination of clinical evaluation, including a thorough assessment of a patient's medical history for potential tick exposure, their reported symptoms, and findings from a physical examination. In many instances, particularly when a patient presents with the characteristic Erythema Migrans (EM) rash, healthcare providers may initiate treatment based on clinical suspicion alone, even before laboratory test results are available.

Several blood tests are used as aids in the diagnosis of Lyme disease. The Enzyme-linked immunosorbent assay (ELISA) is typically the first test employed to detect the presence of antibodies against Borrelia burgdorferi in the patient's blood. If the ELISA test yields a positive or equivocal result, it is usually followed by a Western blot test for confirmation. The Centers for Disease Control and Prevention (CDC) recommends this two-tiered testing approach, using ELISA as an initial screening test followed by Western blot to confirm the results, with the aim of enhancing the accuracy of Lyme disease diagnosis.

Despite the availability of these blood tests, there are significant limitations associated with current diagnostic methods, especially in the early stages of Lyme disease. It can take several weeks for the human body to produce a detectable level of antibodies against the Borrelia bacteria. This means that even if an individual has contracted Lyme disease and is experiencing symptoms, including the EM rash, blood tests conducted in the very early stages of the infection may still come back negative. In fact, it is estimated that current diagnostic tests may miss up to 60% of acute Lyme disease cases. This high rate of missed cases during the early, localized stage of the illness underscores a critical need for more sensitive and reliable diagnostic tools that can identify the infection sooner. Furthermore, it's important to recognize that overreporting of Lyme disease can also occur due to the limitations of serologic tests. These tests detect antibodies, which can remain in the bloodstream for months or even years after a Lyme disease infection has been successfully treated. Consequently, a positive antibody test may not necessarily indicate an active, current infection but could instead reflect a past exposure to the bacteria.

Given these challenges, the process of symptom tracking and obtaining a detailed patient history becomes particularly important in the diagnosis of Lyme disease. Healthcare providers often rely on the patient's account of their symptoms, their recollection of any potential tick bites, and their history of being in environments where ticks are commonly found. The limitations of current blood tests, particularly their reduced sensitivity in the early stages and the potential for positive results to reflect past infections, can lead to delays in accurate diagnosis and the initiation of appropriate treatment. This delay can subsequently increase the risk of the infection progressing to later stages and potentially leading to chronic Lyme disease symptoms. The ongoing research and debate surrounding the development of more accurate and sensitive diagnostic methods for Lyme disease, including the exploration of newer molecular diagnostic techniques, underscore the significant need for advancements in this area. The development of tests capable of directly detecting the Borrelia bacteria itself or identifying very early markers of infection would be invaluable in improving the diagnosis and overall management of Lyme disease, ultimately leading to better outcomes for patients.

Treatment Options: From Antibiotics to Alternative Approaches

The standard treatment for Lyme disease across all stages primarily involves the use of antibiotic medications. The specific antibiotic chosen, the route of administration (oral or intravenous), and the duration of treatment can vary depending on the stage of the disease and the specific symptoms the patient is experiencing.

For early localized Lyme disease, the typical treatment involves a course of oral antibiotics such as doxycycline, amoxicillin, or cefuroxime axetil, usually for a duration of 10 to 14 days. These antibiotics are generally effective in eradicating the Borrelia bacteria and preventing the progression of the disease to later stages.

In cases of early disseminated Lyme disease, where the bacteria have spread throughout the body and may be affecting the nervous system or the heart, treatment may require longer courses of oral antibiotics. In situations involving more severe neurological or cardiac involvement, intravenous antibiotics, such as ceftriaxone, may be necessary to achieve adequate penetration into the affected tissues and effectively combat the infection.

For late disseminated Lyme disease, which can manifest with long-term complications like arthritis or neurological issues, treatment often involves extended courses of oral or intravenous antibiotics. The duration and type of antibiotic used will depend on the specific manifestations of the late-stage disease and the individual patient's response to treatment.

Despite the effectiveness of antibiotic treatment in most cases, a subset of patients continues to experience symptoms such as fatigue, pain, and cognitive difficulties even after completing the standard course of antibiotics. This condition is often referred to as "Post-treatment Lyme Disease Syndrome" (PTLDS) by the Centers for Disease Control and Prevention (CDC). However, many experts in the field prefer the term "persistent Lyme disease," as they believe that in some cases, the ongoing symptoms may be due to the persistence of the Borrelia bacteria in the body. Research has indicated that a significant proportion of individuals treated for Lyme disease, up to 34%, may continue to experience these persistent symptoms. This highlights the considerable number of people who face ongoing health challenges despite undergoing standard antibiotic therapy.

For individuals experiencing chronic Lyme disease symptoms, some may explore alternative therapies in addition to or instead of conventional medical treatments. These alternative approaches can include a wide range of modalities. Some patients may use herbal remedies, believing in their potential to address the underlying infection or alleviate symptoms. It is crucial to emphasize that while some herbal treatments are explored, there is often a lack of robust scientific evidence to support their effectiveness in treating Lyme disease, and it is essential for individuals considering such therapies to discuss them with their healthcare provider to ensure safety and avoid potential interactions with conventional treatments. Another alternative approach that may be used for managing neurological symptoms in some chronic cases is neurocognitive retraining, which aims to improve cognitive function through specific exercises and strategies. It is important to maintain a balanced perspective when discussing alternative therapies for Lyme disease. While acknowledging that some patients may find them helpful, it is equally important to underscore the primacy of evidence-based medical care and the need for rigorous scientific investigation to determine the safety and efficacy of any alternative treatments. The ongoing debate and research into the causes and most effective treatments for persistent Lyme symptoms reflect the complex nature of this condition and the need for a deeper understanding to improve patient outcomes.

Prevention Strategies: Protecting Yourself from Tick Bites

Preventing tick bites is the most effective way to reduce the risk of contracting Lyme disease. By taking simple precautions, individuals can significantly lower their chances of encountering infected ticks.

• Avoid tick-infested areas: Try to stay away from wooded and bushy areas, as well as places with high grass and leaf litter, where ticks are commonly found. When walking on trails, stick to the center to avoid brushing against vegetation where ticks may be present.
• Wear protective clothing: When spending time outdoors, especially in potential tick habitats, wear long sleeves and long pants. Tuck your pants into your socks or boots to prevent ticks from crawling up your legs. Wearing light-colored clothing can make it easier to spot ticks that may have attached to you.
• Use insect repellents: Apply insect repellents that contain DEET (N,N-diethyl-meta-toluamide), picaridin, IR3535, oil of lemon eucalyptus (OLE), para-menthane-diol (PMD), or 2-undecanone. Always follow the product instructions carefully. Repellents can be applied to both skin and clothing. For added protection, clothing can be treated with permethrin, but this should not be applied directly to the skin.
• Check your body thoroughly for ticks: After spending any time outdoors, it is crucial to conduct a thorough check of your entire body for ticks. Pay close attention to areas such as under the arms, in and around the ears, inside the belly button, behind the knees, in and around the hair, between the legs, and around the waist.
• Examine gear and pets: Ticks can also attach to gear such as backpacks and clothing, as well as to pets. Be sure to inspect these items carefully after being outdoors.
• Shower soon after being indoors: Taking a shower within two hours of coming indoors can help wash off any loose ticks that may not have attached yet.
• Remove attached ticks carefully: If you find a tick attached to your skin, remove it as soon as possible using fine-tipped tweezers. Grasp the tick as close to the skin's surface as possible and pull upward with steady, even pressure. Avoid twisting or jerking the tick, as this could cause the mouthparts to break off and remain in the skin. After removing the tick, clean the bite area and your hands thoroughly with rubbing alcohol, an iodine scrub, or soap and water.
• Tick-proof your yard: Take steps to make your yard less hospitable to ticks. This can include clearing tall grass and brush around your home and at the edges of your lawn. Creating a barrier of wood chips or gravel between lawns and wooded areas can also help to deter ticks.

Implementing a combination of these personal protective measures and making modifications to outdoor environments can significantly reduce the risk of tick bites and, consequently, the likelihood of Lyme disease transmission. Consistent adherence to these prevention strategies, particularly during the peak tick activity seasons, which typically span from late spring through summer and into early fall, is of paramount importance. Public health education campaigns play a vital role in effectively communicating these prevention strategies to the public and in raising awareness about the habitats and behaviors of ticks. Increasing public knowledge about how to prevent tick bites and emphasizing the importance of these measures can empower individuals to take control of their own risk and protect themselves and their families from Lyme disease.

Living with Chronic Lyme Disease: Understanding the Long-Term Impact

Individuals living with chronic Lyme disease symptoms often face a multitude of challenges that significantly impact their quality of life. These persistent symptoms can include:

• Persistent and often debilitating fatigue.
• Widespread and chronic pain throughout the body.
• Neurological symptoms such as cognitive dysfunction, including difficulties with memory and concentration, as well as sleep disturbances.
• Emotional difficulties, including anxiety and depression, which can be exacerbated by the chronic nature of the illness and its impact on daily life.
• Significant difficulty in obtaining a definitive diagnosis and accessing appropriate and effective treatment, often due to the complexities of the condition and ongoing debates within the medical community.
• Experiencing skepticism from some healthcare professionals, as well as from the public, regarding the validity and nature of their chronic symptoms.

These persistent health issues can have a profound impact on an individual's ability to perform daily activities, maintain employment or attend school, and overall diminish their quality of life. Managing the long-term effects of chronic Lyme disease often requires a comprehensive and multidisciplinary approach. Strategies that may help individuals cope with and improve their quality of life include:

• A multidisciplinary healthcare team involving physicians with expertise in Lyme disease, as well as therapists and other healthcare professionals who can address the various aspects of the illness.
• Employing various pain management techniques to alleviate chronic pain, which can be a significant and debilitating symptom.
• Engaging in physical therapy and appropriate exercise programs to maintain mobility and strength, as tolerated.
• Participating in cognitive rehabilitation programs to address and improve neurological symptoms such as memory and concentration problems.
• Seeking support through support groups and peer networks, which can provide valuable emotional support, understanding, and practical advice from others who are also living with the condition.

The lack of a universally accepted definition and standardized diagnostic criteria for chronic Lyme disease significantly contributes to the difficulties faced by patients. This can often lead to frustration, feelings of isolation, and challenges in accessing consistent and effective medical care. The ongoing discussions and varying perspectives within the medical community regarding the underlying causes and the most appropriate treatment approaches for persistent Lyme symptoms can create significant barriers for patients seeking the help they need. In caring for individuals with chronic Lyme symptoms, it is of utmost importance for healthcare providers to adopt an approach characterized by empathy, validation, and a focus on the individual patient's experiences. Listening attentively to patients' descriptions of their symptoms and acknowledging the impact these symptoms have on their lives is crucial, even when the precise underlying mechanisms of their illness are not fully understood. Providing compassionate and supportive care, with a focus on managing symptoms and striving to improve overall quality of life, is essential in helping individuals living with chronic Lyme disease navigate the complex health challenges they face.

Conclusion

Lyme disease is a complex and increasingly prevalent tick-borne illness caused by the bacterium Borrelia burgdorferi and transmitted through the bite of infected black-legged ticks. The disease can manifest in three stages, each with a variety of symptoms ranging from the characteristic Erythema Migrans rash and flu-like illness in the early localized stage to neurological and cardiac complications in the early disseminated stage, and potentially leading to arthritis and persistent neurological issues in the late disseminated stage. Diagnosis can be challenging, particularly in the early stages, due to the limitations of current blood tests and the variability of symptoms. While standard antibiotic treatments are effective for most patients, some individuals may develop persistent symptoms even after treatment. Prevention strategies, such as avoiding tick-infested areas, wearing protective clothing, using insect repellents, and performing thorough tick checks, are crucial in reducing the risk of infection. Living with chronic Lyme disease can present significant challenges, highlighting the need for empathetic and comprehensive care.

The increasing global prevalence of Lyme disease underscores its significance as a public health concern. It is vital to raise awareness among both the general public and healthcare professionals about the diverse ways in which Lyme disease can present and the difficulties associated with early diagnosis. Prompt detection and timely treatment are essential to prevent severe complications and the potential development of chronic symptoms. To effectively combat Lyme disease, increased funding and support for research efforts are critical. Research should focus on developing more accurate and sensitive diagnostic tests, especially for early-stage infection and for individuals experiencing persistent symptoms. A better understanding of the underlying mechanisms of chronic Lyme disease is also needed, along with the development of more effective treatment strategies for all stages of the illness. Furthermore, research into innovative prevention methods, such as the development of a Lyme disease vaccine, holds great promise for the future.

Individuals are encouraged to take proactive steps to protect themselves from tick bites and to seek medical attention if they suspect they may have Lyme disease. Supporting Lyme disease advocacy groups and initiatives that work to raise awareness, improve patient care, and advance research is also of paramount importance. Through continued research, education, and advocacy, there is hope for future advancements in our understanding of Lyme disease and in our ability to effectively prevent and treat this complex illness.

Works cited

1. The Global Prevalence of Lyme Disease, accessed April 4, 2025, https://projectlyme.org/the-global-prevalence-of-lyme-disease/
2. Nearly 15% of People Worldwide Have Had Lyme Disease, Study Says - Time, accessed April 4, 2025, https://time.com/6187215/lyme-disease-more-common/
3. At Least 1 in 7 People Worldwide Have Had Lyme Disease - Everyday Health, accessed April 4, 2025, https://www.everydayhealth.com/lyme-disease/at-least-one-in-seven-people-worldwide-have-had-lyme-disease/
4. Lyme Disease Surveillance and Data - CDC, accessed April 4, 2025, https://www.cdc.gov/lyme/data-research/facts-stats/index.html
5. Economic burden of Lyme disease could be nearly $1 billion annually, accessed April 4, 2025, https://ysph.yale.edu/news-article/economic-burden-of-lyme-disease-could-be-nearly-1-billion-annually/
6. Surveillance for Lyme Disease After Implementation of a Revised Case Definition — United States, 2022 | MMWR - CDC, accessed April 4, 2025, https://www.cdc.gov/mmwr/volumes/73/wr/mm7306a1.htm
7. Documented US Lyme disease infections soared in 2022 after updated case definition, accessed April 4, 2025, https://www.cidrap.umn.edu/lyme-disease/documented-us-lyme-disease-infections-soared-2022-after-updated-case-definition
8. Lyme disease cases rose in 2022 due to change in reporting requirements | PBS News, accessed April 4, 2025, https://www.pbs.org/newshour/health/lyme-disease-cases-rose-in-2022-due-to-change-in-reporting-requirements
9. Tick, Tick: Spring Signals the Spread of Lyme Disease in the US - Contagion Live, accessed April 4, 2025, https://www.contagionlive.com/view/tick-tick-spring-signals-the-spread-of-lyme-disease-in-the-us
10. The Surge in Lyme Disease Reports - Contagion Live, accessed April 4, 2025, https://www.contagionlive.com/view/the-surge-in-lyme-disease-reports
11. Lyme Disease - StatPearls - NCBI Bookshelf, accessed April 4, 2025, https://www.ncbi.nlm.nih.gov/books/NBK431066/
12. Why Lyme Disease is on The Rise in the Northeast, accessed April 4, 2025, https://www.vdci.net/blog/lyme-disease-3-reasons-it-is-on-the-rise-in-the-northeast/
13. Climate Change Indicators: Lyme Disease | US EPA, accessed April 4, 2025, https://www.epa.gov/climate-indicators/climate-change-indicators-lyme-disease
14. Why Lyme and other tick-borne diseases are on the rise | PBS News, accessed April 4, 2025, https://www.pbs.org/newshour/science/why-lyme-and-other-tick-borne-diseases-are-on-the-rise
15. Lyme Disease Facts and Statistics, accessed April 4, 2025, https://www.bayarealyme.org/about-lyme/lyme-disease-facts-statistics/